Himax to Integrate WiseEye™ with NVIDIA TAO to Advance AI Vision Deployment in a Robust Ecosystem
TAINAN, Taiwan, June 03, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (NASDAQ: HIMX) (“Himax” or “Company”), a leading supplier and […]
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human […]
ZeroFox to Exhibit External Cybersecurity Platform at Infosecurity Europe
WASHINGTON, June 03, 2024 (GLOBE NEWSWIRE) — ZeroFox, the leader in external cybersecurity, will exhibit at the 2024 Infosecurity Europe […]
WTW ushers in next generation of climate risk technology with launch of Climate Quantified™
LONDON, June 03, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today unveiled […]
Pharming Group to participate in June investor conferences
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate […]
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
GUANGZHOU, China, June 03, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or […]
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
— AMD Ryzen™ AI 300 Series Processors Unlock Transformational AI Experiences for Windows Copilot+ PCs — — AMD Ryzen™ 9000 […]
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
— Updated AMD Instinct accelerator roadmap brings annual cadence of leadership AI performance and memory capabilities — — New AMD […]
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
— Expanded AMD Instinct accelerator roadmap brings annual cadence of leadership AI accelerators; next generation AMD EPYC processors to extend […]
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
Phase III collaboration will evaluate efti in combination with KEYTRUDA, MSD’s anti-PD-1 therapy, and standard chemotherapy in first-line non-small cell […]
